AnaptysBio's total assets for Q4 2025 were $364.39M, an increase of 3.20% from the previous quarter. ANAB total liabilities were $327.19M for the fiscal quarter, a -14.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.